Please assess the completion status of the following clinical trial:

Trial Title: ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be ≥18 years of age and ≤ 65 years~2. Have symptoms consistent with dyspepsia of at least two weeks duration (defined as recurrent pain or discomfort centered in the upper abdomen, often with a relation to meals)~3. Be positive for H. pylori by 13C Urea Breath Test (UBT) and also by fecal antigen test~4. Be informed of the nature of the study and provide written informed consent before any study specific procedures are performed (or have a legally authorized representative sign consent)~Exclusion Criteria:~1. Have alarm symptoms/signs (including unexplained anemia \[iron deficiency), melena / hematemesis, anorexia, dysphagia, jaundice, weight loss)~2. Have taken antibiotics in the 4 weeks prior to screening~3. Have taken bismuth containing medications such as peptobismol in the 4 weeks prior to screening~4. Have a history of any previous esophageal or gastric surgery, except for simple closure of perforated ulcer~5. Have a history of gastric outlet obstruction~6. Have a history of hypersecretory state such as Zollinger-Ellison Syndrome~7. Have a history of gastric cancer~8. Have the presence of active gastric and duodenal ulcers or presence of 3 or more active ulcers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- RHB-105 (Type: EXPERIMENTAL): RHB-105 is an 'all-in-one' combination oral capsule consisting of 2 different antibiotics and a proton pump inhibitor combined in a single capsule.
- Placebo (Type: PLACEBO_COMPARATOR): Capsules that look like the RHB-105 product but contain no active ingredient.

Based on this trial design, predict the completion outcome and termination type (if applicable).